We’re one of the only clinics in the United States offering stem cell therapies that has a research department and uses a registry to track patients and publish the results of our patients. To that end, we just published another study as a safety update for Regenexx-C stem cell therapy as well as knee outcome data for severe knee arthritis patients. This complication study tracked 339 patients for up to 4 years (our last study looked at 227 patients for 2-3 years) and involved over 200 research grade MRI’s of 50 patients to ensure that the cultured stem cells had produced no problems. In addition, this new study publishes additional knee data showing very good results when all patients are factored in (not just the patients that did well with stem cell therapy, but also the patients that didn’t respond). We’re proud of our commitment to research the Regenexx family of procedures.
